4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-029030
Chief Executive Officer bought 10,500 shares at $0.25 ($2,625)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-16 | Purchase : show line 1 in the form | +10,500 | $0.25 | $2,625 | 94,430 | D |
| Open-market purchases · 10,500 sh · avg $0.25 · $2,625 | ||||||
Loading xslF345X03/doc4.xml…